C
CYTK icon

Certuity’s Cytokinetics CYTK Stock Holding History

Certuity’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$503K Buy
5,904
+15
+0.3% +$1.08K 0.02% 336
2026
Q1 		$388K Hold
5,889
– – 0.03% 363
2025
Q4 		$374K Sell
5,889
-700
-11% -$43.5K 0.02% 345
2025
Q3 		$362K Buy
+6,589
New +$271K 0.02% 341
2025
Q2 		– Sell
-9,204
Closed -$370K – 436
2025
Q1 		$370K Buy
9,204
+4,000
+77% +$184K 0.04% 228
2024
Q4 		$245K Buy
5,204
+148
+3% +$7.69K 0.03% 306
2024
Q3 		$267K Hold
5,056
– – 0.03% 287
2024
Q2 		$274K Buy
5,056
+56
+1% +$3.38K 0.02% 276
2024
Q1 		$351K Buy
+5,000
New +$387K 0.03% 223

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Certuity's CYTK Position: Q2 2026 in Review

Certuity increased its Cytokinetics (CYTK) stake by 0.25% in Q2 2026, buying an estimated $1.08K and bringing the position to 5,904 shares worth $503K. The position accounts for 0.02% of the portfolio, ranked #336.

Certuity first reported a position in CYTK in Q1 2024 and has held it in 9 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Certuity held 5,904 shares of Cytokinetics worth $503K as of Q2 2026.
  • Certuity bought 15 Cytokinetics shares in Q2 2026, an estimated $1.08K.
  • Cytokinetics made up 0.02% of Certuity's portfolio in Q2 2026, its #336 holding.
  • Certuity first reported a position in Cytokinetics in Q1 2024 and has held it in 9 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.